# VALSARTAN AND HYDROCHLOROTHIAZIDE
> **ANDA202519** · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2013-03-21
## Drug
- **FDA Application Number:** ANDA202519
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VALSARTAN AND HYDROCHLOROTHIAZIDE
- **Generic name:** VALSARTAN AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; VALSARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AUROBINDO PHARMA LTD
- **Manufacturer:** Aurobindo Pharma Limited
- **First approval:** 2013-03-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202519)
---
*AI Analytics · CC0 1.0*